Research Efforts - Reports and Information from the LFA
Access: Lupus Research
"Access: Lupus Research," produced in collaboration with patientINFORM, presents summaries of late-breaking research published in respected medical journals that report on lupus and related conditions.
- Antiphospholipid Syndrome
- Blood Components
- Cardiovascular Disease
- Clinical Trials
- Cutaneous Lupus
- Drug-Induced Lupus
- Flu Vaccines
- Lupus Biomarkers
- Lupus Complications
- Lupus Diagnosis
- Lupus Disease Activity
- Lupus Drug Development
- Lupus Flares
- Lupus Nephritis
- Lupus Treatments
- Male Lupus
- Neonatal Lupus
- Neuropsychiatric Lupus
- Organ Damage
- Pediatric Lupus
- Pregnancy & Reproductive Issues
- Quality of Life
- Sexually Transmitted Diseases
- Stem Cells
- Thyroid Disease
Behind every new treatment are volunteers who participate in clinical research studies.
Every advance in the understanding of a disease such as lupus—its causes, its effects on the body, the development of new drugs and treatments—is based on research.
The Lupus Foundation of America’s Center for Clinical Trials Education is the resource for people with lupus and their families who want to learn about clinical trials.
The LFA Center provides:
- a comprehensive search tool for clinical trials
- points to consider before participating in a clinical trial
- a guide to clinical research terms
- the latest news on lupus and clinical research
- resources for additional information and support
Learn More About the LFA CCTE
Join the Lupus Research Registry to help make new treatments for lupus a reality.
Georgia Lupus Registry
Each of the registries represents a different geographic area and contains large number of people at risk for lupus. The Georgia registry is led by the division of Rheumatology at Emory University in partnership with the Georgia Department of Human Resources (DHR).
The Georgia Lupus Registry (GLR) aims to develop, implement, and support a population based disease registry to determine the prevalence and incidence of systemic lupus within Fulton, DeKalb, and Richmond (Augusta) counties. Acting as public health agents under the auspices of GA DHR, the registry will identify as many hospitals and practitioners as possible who are providing care to potential lupus patients. These are rheumatologists, nephrologists, dermatologists, obstetricians, cardiologists, neurologists, and hematologists, as well as internists and primary care physicians. The LFA Georgia chapter helps identify patients and their healthcare providers.
The results of the Georgia Lupis Registry and biomarker research funded by the Department of Defense could help accelerate the introduction of new therapies and treatment of lupus patients. There has not been a new FDA approved drug for lupus for over 40 years.
Sam Lim MD, MPH, Assistant Professor Medicine
Read the Wall Street Journal Article "Drugs in testing show promise for treating lupus" - Dr. Sam Lim quoted.